Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2024-01-30T11:20:46

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg GLIMITERIS TRIO 0.3 The combination of Voglibose, Glimepiride, and Metformin Hydrochloride represents a multi-faceted approach to managing type 2 diabetes mellitus. Each of these medications works through a different mechanism to help control blood glucose levels: Voglibose: Class: Alpha-glucosidase inhibitor. Mechanism of Action: Voglibose works by delaying the digestion and absorption of carbohydrates in the intestines. This results in a slower and lower rise in blood glucose level post meals. Usage: It's particularly effective in controlling postprandial (after-meal) blood glucose spikes. Glimepiride: Class: Sulfonylurea. Mechanism of Action: Glimepiride increases insulin production from the pancreas. Insulin is a hormone that helps lower blood glucose levels by facilitating the uptake of glucose into the cells. Usage: It's used to improve blood sugar control in adults with type 2 diabetes. However, it can cause hypoglycemia (low blood sugar), particularly if meals are skipped or delayed. Metformin Hydrochloride: Class: Biguanide. Mechanism of Action: Metformin works by decreasing glucose production in the liver, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. Usage: It's often used as a first-line treatment for type 2 diabetes and is particularly helpful for overweight or obese patients. It does not usually cause hypoglycemia when used alone. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/glimiteris-trio-0-3-134375

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg GLIMITERIS TRIO 0.3 The combination of Voglibose, Glimepiride, and Metformin Hydrochloride represents a multi-faceted approach to managing type 2 diabetes mellitus. Each of these medications works through a different mechanism to help control blood glucose levels: Voglibose: Class: Alpha-glucosidase inhibitor. Mechanism of Action: Voglibose works by delaying the digestion and absorption of carbohydrates in the intestines. This results in a slower and lower rise in blood glucose level post meals. Usage: It's particularly effective in controlling postprandial (after-meal) blood glucose spikes. Glimepiride: Class: Sulfonylurea. Mechanism of Action: Glimepiride increases insulin production from the pancreas. Insulin is a hormone that helps lower blood glucose levels by facilitating the uptake of glucose into the cells. Usage: It's used to improve blood sugar control in adults with type 2 diabetes. However, it can cause hypoglycemia (low blood sugar), particularly if meals are skipped or delayed. Metformin Hydrochloride: Class: Biguanide. Mechanism of Action: Metformin works by decreasing glucose production in the liver, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. Usage: It's often used as a first-line treatment for type 2 diabetes and is particularly helpful for overweight or obese patients. It does not usually cause hypoglycemia when used alone. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/glimiteris-trio-0-3-134375

  • 2024-01-30T11:20:46

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us